EDGAR Filing Documents for 0001193125-22-076072

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001193125-22-076072

Filing Date

2022-03-15

Accepted

2022-03-15 16:19:42

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	S-3	d296045ds3.htm	S-3	406590
2	EX-1.2	d296045dex12.htm	EX-1.2	181110
3	EX-4.2	d296045dex42.htm	EX-4.2	298784
4	EX-4.4	d296045dex44.htm	EX-4.4	96843
5	EX-4.5	d296045dex45.htm	EX-4.5	102611
6	EX-4.6	d296045dex46.htm	EX-4.6	85851
7	EX-5.1	d296045dex51.htm	EX-5.1	27827
8	EX-23.1	d296045dex231.htm	EX-23.1	1532
9	EX-FILING FEES	d296045dexfilingfees.htm	EX-FILING FEES	29370
10	GRAPHIC	g296045g04a04.jpg	GRAPHIC	25875
11	GRAPHIC	g296045g08k39.jpg	GRAPHIC	68368
12	GRAPHIC	g296045g51h51.jpg	GRAPHIC	34088
13	GRAPHIC	g296045g85g38.jpg	GRAPHIC	10139
	Complete submission text file	0001193125-22-076072.txt		1407401

Mailing Address 620 PROFESSIONAL DRIVE GAITHERSBURG MD 20879

Business Address 620 PROFESSIONAL DRIVE GAITHERSBURG MD 20879 (240) 243-8000

Sensei Biotherapeutics, Inc. (Filer) CIK: 0001829802 (see all company filings)